Stockreport

Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering

Praxis Precision Medicines, Inc.  (PRAX) 
PDF BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights int [Read more]